Grifols SA increased its profits by 27% in the fourth quarter, shifting the focus back to the embattled healthcare company’s growth prospects after a short-seller’s allegations of fraud wiped billions of euros off its value.
Barcelona-based Grifols posted adjusted earnings before interest, taxes, depreciation, and amortization of €442 million ($479 million) for the quarter ended Dec. 31, according to a regulatory statement Thursday. Analysts had expected an average of €430 million, according to a survey by Bloomberg.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.